Market Insights Health Hospitals Inpatient Care

Gastroenterology - Worldwide

Worldwide

The Gastroenterology market worldwide is anticipated to witness a significant surge in revenue, with projections indicating that it will reach a staggering value of €175.40bn by the year 2024.
Furthermore, this market is expected to exhibit a steady growth rate of 2.98% annually between 2024 and 2029, culminating in a market volume of €203.10bn by the end of the latter year.
In terms of global comparison, it is worth noting that United States is poised to generate the highest revenue in this sector, with an estimated value of €56,090.00m in 2024.
In the United States, there is a growing trend towards incorporating probiotics into the treatment plans for gastrointestinal disorders.

Key regions: France, China, Japan, United States, Europe

Marché

Région

Comparaison de régions

Monnaie

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.